Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Insomnia Management in Patients with PEG Tubes

  • The American Academy of Sleep Medicine recommends doxepin liquid at 3-6 mg doses for sleep maintenance insomnia, available in liquid form making it ideal for PEG tube administration 4, 5
  • Melatonin liquid can be safely administered through PEG tubes, though not strongly recommended for primary insomnia treatment by guidelines 4, 6
  • Trazodone can be crushed and dissolved in water for PEG tube administration, typically used at 50 mg doses, though evidence for insomnia is limited 1, 3
  • Mirtazapine can be crushed and dissolved for PEG tube administration, sedating properties make it useful for insomnia, especially in patients with comorbid depression 1, 3
  • Zolpidem immediate-release formulations can be crushed and dissolved, but controlled-release formulations should not be crushed, recommended at 5-10 mg doses 4, 6
  • Zaleplon can potentially be opened from capsule form and mixed with water for administration, used at 5-10 mg doses for sleep onset insomnia 4

Administration Considerations

  • Medications should be thoroughly crushed to a fine powder or use liquid formulations when available, and dissolved completely in 15-30 mL of water before administration 5, 7
  • Flush the PEG tube with 15-30 mL of water before and after medication administration to prevent clogging 7
  • Administer each medication separately with appropriate water flushes between medications 7
  • Never crush extended-release or enteric-coated formulations as this can lead to dose dumping and potential toxicity 7
  • Controlled-release formulations of zolpidem, eszopiclone, and certain benzodiazepines should not be crushed 4, 6
  • Consider potential drug interactions with other medications being administered through the PEG tube 1, 3
  • Monitor for increased side effects due to potential changes in absorption when medications are crushed 7

Medication Selection and Monitoring

  • Assess insomnia type to determine if patient has sleep onset or sleep maintenance insomnia 1, 3
  • Prioritize medications available in liquid formulations 7
  • For sleep maintenance insomnia, consider doxepin liquid (3-6 mg) 4, 5
  • For sleep onset insomnia, consider crushed immediate-release zolpidem (5-10 mg) or zaleplon (5-10 mg) if appropriate 4, 6
  • For patients with depression and insomnia, consider crushed mirtazapine or trazodone 1, 3
  • Assess efficacy of the medication 1-2 weeks after initiation 1, 3
  • Monitor for side effects including excessive sedation, confusion, and falls, especially in elderly patients 1, 4
  • Evaluate PEG tube function regularly to ensure it remains patent after medication administration 7

REFERENCES

1

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

3

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

4

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

5

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008